STERIS Q1 revenue rises 45% to $968.4M; raises outlook and dividend

STERIS plc

2022-Q1 EPS reported -$0.24 revenue$968,422,000

Revenue $968.4M, up 45% as reported vs. $668.9M in Q1 FY21; constant currency organic revenue up 21%.
Cantel Medical integration on track; company increases full-year outlook (specific targets not disclosed in snippet).
Quarterly dividend raised (amount not specified in press release excerpt).
First-quarter results reflect strong demand across healthcare and life sciences segments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.